Targeted Therapies and their Impact on Melanoma
Steven O’Day, MD
Video Categories: Targeted Therapies
Jayson Slotnick discusses the definition and feasibility of personalized medicine
Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.